InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Claire Mazumdar, Chief Executive Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 14 open-market SEC Form 4 transactions: 0 purchases worth $0 and 14 sales worth $3.7M, reported from Oct 13, 25 to Jul 10, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 10, 26 | BCAXBicara Therapeutics Inc. | SELL | 10.0K | $29.68 | $283K |
| May 18, 26 | BCAXBicara Therapeutics Inc. | SELL | 12.0K | $20.35 | $240K |
| Apr 20, 26 | BCAXBicara Therapeutics Inc. | SELL | 15.0K | $23.61 | $354K |
| Mar 20, 26 | BCAXBicara Therapeutics Inc. | SELL | 1.6K | $18.95 | $30K |
| Mar 19, 26 | BCAXBicara Therapeutics Inc. | SELL | 6.9K | $18.78 | $130K |
| Mar 18, 26 | BCAXBicara Therapeutics Inc. | SELL | 6.5K | $18.84 | $122K |
| Mar 9, 26 | BCAXBicara Therapeutics Inc. | SELL | 36.8K | $19.17 | $705K |
| Mar 6, 26 | BCAXBicara Therapeutics Inc. | SELL | 3.8K | $18.75 | $72K |
| Mar 5, 26 | BCAXBicara Therapeutics Inc. | SELL | 1.8K | $18.74 | $33K |
| Mar 4, 26 | BCAXBicara Therapeutics Inc. | SELL | 2.6K | $18.73 | $49K |
| Nov 24, 25 | BCAXBicara Therapeutics Inc. | SELL | 41.2K | $18.86 | $776K |
| Oct 16, 25 | BCAXBicara Therapeutics Inc. | SELL | 24.1K | $18.83 | $454K |
| Oct 15, 25 | BCAXBicara Therapeutics Inc. | SELL | 13.3K | $18.84 | $250K |
| Oct 13, 25 | BCAXBicara Therapeutics Inc. | SELL | 11.4K | $18.92 | $217K |